Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Champions Oncology (CSBR) Receivables - Other (2016 - 2026)

Champions Oncology has reported Receivables - Other over the past 16 years, most recently at $6.2 million for Q1 2026.

  • Quarterly results put Receivables - Other at $6.2 million for Q1 2026, up 6.36% from a year ago — trailing twelve months through Jan 2026 was $6.2 million (up 6.36% YoY), and the annual figure for FY2025 was $5.4 million, down 9.14%.
  • Receivables - Other for Q1 2026 was $6.2 million at Champions Oncology, down from $7.2 million in the prior quarter.
  • Over the last five years, Receivables - Other for CSBR hit a ceiling of $7.2 million in Q4 2025 and a floor of $3.7 million in Q1 2023.
  • Median Receivables - Other over the past 5 years was $5.0 million (2023), compared with a mean of $5.1 million.
  • Biggest five-year swings in Receivables - Other: decreased 10.7% in 2023 and later soared 65.77% in 2024.
  • Champions Oncology's Receivables - Other stood at $4.3 million in 2022, then dropped by 7.28% to $4.0 million in 2023, then soared by 65.77% to $6.6 million in 2024, then increased by 8.09% to $7.2 million in 2025, then dropped by 14.17% to $6.2 million in 2026.
  • The last three reported values for Receivables - Other were $6.2 million (Q1 2026), $7.2 million (Q4 2025), and $5.3 million (Q3 2025) per Business Quant data.